Howard H. Erickson, DVM, PhD, et al. "Review of Alternative Therapies for EIPH", Proceedings of the 53rd Annual Convention of the American Association of Equine Practi-
Kansas State University, College of Veterinary Medicine
Almost 400 Thoroughbred horses that wore nasal strips were evaluated at the Calder Race Course in Florida in 1999-2000. The horses with the strip had a win percentage
3.4% higher than horses that did not wear a strip. Horses wearing a nasal strip also had a 15% decrease in the interval to the next race (23 days) compared with the race-to-race
interval before wearing a nasal strip (29 days).
McDonough, P. et al. "Effect of Furosemide and the Equine Nasal Strip on Exercise-Induced Pulmonary Haemorrhage and Time-to-Fatigue in Maximally Exercising Horses,"
Equine and Comparative Exercise Physiology. Volume 1: Number 3, 177-184, August 2004.
Kansas State University, College of Veterinary Medicine
Six thoroughbred horses were exercised on a treadmill at near-maximal running to fatigue under the following conditions: control (C); wearing nasal strips (NS); medicated with
furosemide (NS + F); and wearing nasal strips and medicated with furosemide (NS+F). "A very interesting , and novel, finding of the current investigation is that while both
FUR and the NS reduced EIPH severity, the NS was equally as effective as FUR during maximal running to fatigue." Both FUR and NS caused an increased time-to-fatigue. As
in previous studies of the nasal strip, VO2 was reduced, probably due to reduction of the O2 cost of breathing. In theory, this additional O2 should be available for distribution
within the contracting locomotory muscles, if needed, thereby increasing the time to fatigue.
Valdez , Sandra C., MVZ et al. "Effect of an External Nasal Dilator Strip on Cytologic Characteristics of Bronchoalveolar Lavage Fluid in Thoroughbred and Racehorses."
Journal of American Veterinary Medical Association. Volume 224: Number 4, 558-561, February 15, 2004.
University of California, Davis, College of Veterinary Medicine
23 thoroughbred racehorses in active training at Golden Gate Fields Racetrack in California were raced with and without FLAIR Equine Nasal Strips. All horses were administe-
red furosemide 4 hours before each race. Mean red blood cell count in BAL fluid in horses with severe bleeding was significantly reduced when wearing nasal strips. The mean
lymphocyte count was also significantly reduced in BAL fluid of horses when wearing nasal strips.
Holcombe, Susan J. VMD, PhD et al. "Effect of Commercially Available Nasal Strips on Airway Resistance in Exercising Horses." American Journal of Veterinary Research.
Volume 63: Number 8, 1101-1105, August 2002.
Michigan State University, College of Veterinary Medicine
Six horses were exercised on a treadmill at speeds corresponding to 100 and 120% maximal heart rate with and without application of Flair Strips. Tracheal pressures, airflow,
and heart rate were measured. Main effects of the nasal strip were a significant decrease in inspiratory airway resistance and a significantly lower negative peak tracheal inspi-
ratory pressure. The researchers stated that nasal strips probably decrease the amount of work required for respiratory muscles in horses during intense exercise and may reduce
Geor, Ray J. PhD et al. "Effects of an External Nasal Strip and Frusemide on Pulmonary Hemorrhage in Thoroughbreds Following High-Intensity Exercise." Equine Veterinary
Journal. Volume 33: Number 6, 577-584, 2001.
Eight thoroughbred horses were exercised at 120% maximal oxygen consumption (VO2max) by sprinting on a high speed treadmill under the following conditions: control (c);
wearing FLAIR Equine Nasal Strips (ns); medicated with furosemide (f); wearing FLAIR Equine Nasal Strips and medicated with furosemide (NS+F). Horses treated with furo-
semide carried weight equal to that caused by fluid loss after furosemide administration. Horses wearing FLAIR Strips showed a significant reduction of EIPH based on analysis
of BAL fluid. Horses injected with furosemide showed a greater reduction in EIPH. Both VO2 and CO2 were significantly lowered in the NS and NS + FR trials over control.
The researchers concluded that "the external nasal strip appears to lower the metabolic cost of supramaximal exertion in horses."
"A decrease in the work of breathing during maximal exercise might also be expected to result in a redistribution of blood flow from the respiratory muscles to the muscles of
locomotion with a concomitant increase in locomotory muscle VO2."
Kindig, Casey A. PhD et al. "Efficacy of Nasal Strip and Furosemide in Mitigating EIPH in Thoroughbred Horses." Journal of Applied Physiology. Volume 91: 1396-1400,
Kansas State University, College of Veterinary Medicine
Five thoroughbred horses were exercised on a high speed treadmill at near maximal efforts four times under the following conditions: control; wearing FLAIR Equine Nasal
Strips; medicated with Furosemide; wearing FLAIR Equine Nasal Strips and medicated with Furosemide. Horses wearing FLAIR Strips showed a significant reduction of
EIPH based on analysis of BAL fluid. And, although horses injected with furosemide showed a greater reduction in EIPH, there was no further reduction in EIPH when wearing
FLAIR and medicated with furosemide.
Poole, David C., PhD et al. "Effects of External Nasal Support on Pulmonary Gas Exchange and EIPH in the Horse." Journal of Equine Veterinary Science. Volume 20: Number
Kansas State University College of Veterinary Medicine
Seven horses were exercised on a high speed treadmill with and without FLAIR¨ Equine Nasal Strips. When wearing Nasal Strips V02 was significantly reduced indicating a
reduction in the work of breathing. Broncho-alveolar lavage (BAL) fluid analysis also showed a significant reduction in the number of red blood cells recovered from the lungs
of horses when wearing the FLAIR Strips as compared to the control run.
Allegato 2 : Farmaci da Sottoporre all’Assessorato alla Sanita, Settore Farmaceutico, Tavolo Tecnico Permanente di Lavoro sul Farmaco, ex D.P.G.R.C. 11279 del 5-7 99 A06 AB Sodio Picosolfato 7,5 mg /ml gtt orali A07FA Lactobacillo buste NOTA: Solo in PZ pediatrici con gastroenterite acuta A11CC05 Paricalcitolo 5mcg/ml fl IV B01AD10 Drotrecogin alfa attivato 5mg fl IV Drotrecogin
ARTICLE IN PRESS Medical Engineering & Physics xxx (2006) xxx–xxxPhotoacoustic monitoring of the absorption ofF.L. Dumas , F.R. Marciano , L.V.F. Oliveira , P.R. Barja , D. Acosta-Avalos a Instituto de Pesquisa e Desenvolvimento (IP&D), Universidade do Vale do Paraiba, Av. Shishima Hifumi 2911, CEP 12244-000, S˜ao Jos´e dos Campos, SP, Brazil b Centro Brasileiro de Pes